Such discovery might help to decipher the pharmacological mechanism of MX with a lower bioavailability, but it can exert significantly inhibitory role on CRC tumor by targeting the dysregulate gut microbiota and associated metabolism. Here, MX1 is linked to colorectal carcinoma.